| 1 | DBT/BIRAC-NBM Supported Phase I/II Clinical Trials | 08/06/2021 | विवरण |
| 2 | DBT-ILS establishes Animal Challenge Study Platform | 07/06/2021 | विवरण |
| 3 | DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9 | 04/06/2021 | विवरण |
| 4 | Union Ministry of Health finalises advance arrangement with M/s Biological-E Ltd., Hyderabad for 30 cr COVID19 Vaccine doses | 03/06/2021 | विवरण |
| 5 | Centre takes steps to accelerate domestic vaccine production | 02/06/2021 | विवरण |
| 6 | सरकार ने मिशन कोविड सुरक्षा के तहत कोवैक्सीन के उत्पादन के लिए उत्पादन क्षमता बढ़ाने में सहायता दी | 15/05/2021 | विवरण |
| 7 | DBT-BIRAC Supported ‘Virafin’ from Zydus Gets Emergency Nod For Treating Moderate COVID-19 Infections In Adults | 24/04/2021 | विवरण |
| 8 | Department of Biotechnology organizes Public Webinar on the “Genome Sequencing of SARS-CoV-19” | 24/04/2021 | विवरण |
| 9 | Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha | 16/04/2021 | विवरण |
| 10 | HGCO19: starting the enrolment for the PhaseI/II human clinical trials | 13/04/2021 | विवरण |
